References
- Schwartz RH, Wientzen Jr RL, Pedreira F, Feroli EJ, Melia GW, Guandolo VL. Penicillin V for group A streptococcal pharyngotonsillitis. A randomized trial of seven vs. ten days' therapy. JAMA 1981; 246: 1790–5.
- Strömberg A, Schwan A, Cars O. Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phe-noxymethylpenicillin and cefadroxil. Scand J Infect Dis 1988; 20: 37–46.
- Sanders C, Sanders E, Harrow D. Bacterial interfer-ence: effects of oral antibiotics on the normal throat flora and its ability to interfere with group A strepto-cocci. Infect Immun 1976; 13: 808–12.
- Kim KS, Kaplan EL. Association of penicillin toler-ance with failure to eradicate group A streptococci from patients with pharyngitis. J Pediatr 1985; 107: 681–4.
- Smith TD, Huskins WC, Kim KS, Kaplan EL. Efficacy of B-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. J Pediatr 1987; 110: 777–82.
- Orrling A, Stjernquist-Desatnik A, Schalén C, Kamme C. Treatment failure in streptococcal pharyngotonsilli-tis. An attempt to identify penicillin tolerant Strepto-coccus pyogenes. Scand J Infect Dis 1996; 28: 143–7.
- Brook I. Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A strepto-cocci. Pediatr Infect Dis 1985; 4: 491–5.
- Tuner K, Nord CE. Emergence of beta-lactamase pro-ducing anaerobic bacteria in the tonsils during peni-cillin treatment. Eur J Clin Microbiol Infect Dis 1986; 5: 399–404.
- Orrling A, Stjernquist-Desatnik A, Schalén C, Kamme C. Clindamycin in persisting streptococcal pharyngo-tonsillitis after penicillin treatment. Scand J Infect Dis 1994; 26: 535–41.
- Kaplan EL, Johnson DR. Eradication of group A streptococci from the upper respiratory tract by amoxi-cillin with clavulanate after oral penicillin V treatment failure. J Pediatr 1988; 113: 400–3.
- DeDio RM, Tom LWC, McGowan KL, Wetmore RF, Handler SD, Potsic WP. Microbiology of the tonsils and adenoids in a pediatric population. Arch Otolaryn-gol Head Neck Surg 1988; 114: 763–5.
- Brodsky L, Moore L, Stanievich J, Ogra PL. The immunology of tonsils in children. The effect of bacte-rial load on the presence of B- and T-cell subsets. Laryngoscope 1988; 98: 93–8.
- Brook I, Yocum P, Shah K. Surface vs. core-tonsillar aerobic and anaerobic flora in recurrent tonsillitis. JAMA 1980; 244: 1696–8.
- Stjernquist-Desatnik A, Prellner K, Schalén C. High recovery of Haemophilus influenzae and group A strep-tococci in recurrent tonsillar infection or hypertrophy as compared with normal tonsils. Laryngol Otol 1991; 105: 439–41.
- Brook I, Foote PA. Microbiology of "normal" tonsils. Ann Otol Rhinol Laryngol 1990; 99: 980–3.
- Brodsky L, Moore L, Stanievich J. The role of Haemophilus influenzae in the pathogenesis of tonsillar hypertrophy in children. Laryngoscope 1988; 98: 1055–60.
- Roos K. The diagnostic value of symptoms and signs in acute tonsillitis in children over the age of 10 and in adults. Scand J Infect Dis 1985; 17: 259–67.
- Holm SE, Roos K, Stromberg A. A randomized study of treatment of streptococcal pharyngotonsillitis with cefadroxil or phenoxymethyl-penicillin (penicillin V). Pediatr Infect Dis 1991; 10: 68–71.
- Ebenfelt A, Lundberg C. Bacterial invasion of the tonsillar tissues in acute pharyngotonsillitis and in the adenoid: a preliminary study. Clin Otolaryngol 1994; 16: 310–3.
- Roos K, Grahn E, Ekedahl C, Holm S. Pharmacoki-netics of phenoxy-methylpenicillin in tonsils. Scand J Infect Dis 1986; 18: 125–30.
- Stjernquist-Desatnik A, Samuelsson P, Walder M. Pen-etration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsilli-tis. Laryngol Otol 1993; 107: 309–12.
- La Penta D, Rubens C, Chi E, Cleary P. Group A streptocowcci efficiently invade human respiratory ep-ithelial cells. Proc Natl Acad Sci USA 1994; 91: 12115–9.